{"name":"Cipher Pharmaceuticals Inc.","slug":"cipher-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CIP-Isotretinoin","genericName":"CIP-Isotretinoin","slug":"cip-isotretinoin","indication":"Acute promyelocytic leukemia (APL)","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Spinosad Topical","genericName":"Spinosad Topical","slug":"spinosad-topical","indication":"Head lice (Pediculosis capitis)","status":"marketed"}]}],"pipeline":[{"name":"CIP-Isotretinoin","genericName":"CIP-Isotretinoin","slug":"cip-isotretinoin","phase":"phase_3","mechanism":"CIP-Isotretinoin is a retinoid that binds to nuclear retinoid receptors to regulate gene expression and promote differentiation and apoptosis of abnormal cells.","indications":["Acute promyelocytic leukemia (APL)","High-risk neuroblastoma (maintenance therapy)"],"catalyst":""},{"name":"Spinosad Topical","genericName":"Spinosad Topical","slug":"spinosad-topical","phase":"marketed","mechanism":"Spinosad is a natural insecticide that activates nicotinic acetylcholine receptors and GABA-gated chloride channels in insects, causing paralysis and death.","indications":["Head lice (Pediculosis capitis)","Body lice (Pediculosis corporis)","Pubic lice (Phthirus pubis)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE1Zc0VPTzVURTNaREZOSGljMkdVTXNHYnhHT0dzWF9FSXJIU1k4X3Z2RWtrVEtsWGtyN3VFUFVvR2VqQVdhczQxTXl3MWFtWXdQQmlhMw?oc=5","date":"2026-04-07","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Cipher Pharmaceuticals Inc. (CPH.TO) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Cipher Pharmaceuticals Inc. (CPH.TO) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxPUjA1djQ5N3U5REtyc0NKRjFsb3B0TXVxTGlCM0M0QUhvd2hsWlpPbXhodWJZU2d0SjUzLS02VHVpOTlwME9Fdm1EWGN0QWRKc1VCSGRoWk9oRXVHWHZROGllNnN1ODltQzZfM3h3UjJUZF96T3Y3TjQzdnY3bzZBTHZfWE9VdDRJdU1HLS04WmFjWHdnazRmOUczQ0hRaWFQS3h5Z3hLYU1OZTVodXNTX2ZOSkZwMi1uQ2ozeXJGLWJiT1JnSUJGek5MdnpmRG5UblhiQUNuNC0tVGdGc2lF?oc=5","date":"2026-04-07","type":"pipeline","source":"Business Wire","summary":"CaryHealth Launches Direct-to-Patient Program for Cipher Pharmaceuticals’ Natroba (spinosad) - Business Wire","headline":"CaryHealth Launches Direct-to-Patient Program for Cipher Pharmaceuticals’ Natroba (spinosad)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOODhYcDFUR1NnOWZRUWc1SF9iODhEZVhUY3dPSXItd0MtY0dLY1dsRnlTdEpfUjNCYnhLTVJVNTkzNlFPMWhnOGZnTm9uWVVBb3ZNd29PZEpVODc0blIzaXFOYjRlTFhfV2tmblR0SkxlUnp1ZTFtTVdMd25zVlpmckZlQzZaSmdNbGpJN1Q4aHZMSWxpdHlZejVZLVg3ZGIwaktpa1RrenpaZ3ZhSXI0dWM3VExSUU03WFJEY2tBQQ?oc=5","date":"2026-03-13","type":"pipeline","source":"MarketBeat","summary":"Cipher Pharmaceuticals (TSE:CPH) Stock Price Up 15.6% - Here's What Happened - MarketBeat","headline":"Cipher Pharmaceuticals (TSE:CPH) Stock Price Up 15.6% - Here's What Happened","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOSjVtcFUzSEMwMXI2WjY2dFRveWZFajFrenR2TE5FS29iUmFnZlUtclhfdHBrQmpDR0UzTHZtWXpaYm9mX1YxOGp2cEN2dWZtR0JhUzE1NFRYWHl1dTFQZ1IzdHVaOWRoaU5GbzNHTWVMM0hmQ2dsUE00bFNqRVFxSm5Sbm9Ncnd5QXh4Q3RmcEZsOVo1M05aX2czNmd5ZUdtNGY4Wml4OW5adDBnVEl5QW1TSG4tNnZocGs5SXJaSURZOHlIaGNwb0JselBoZGNzRHRhdmI0bGM?oc=5","date":"2026-03-12","type":"trial","source":"TipRanks","summary":"Cipher Pharmaceuticals Delivers Record 2025 Results and Primes for Next Acquisition Phase - TipRanks","headline":"Cipher Pharmaceuticals Delivers Record 2025 Results and Primes for Next Acquisition Phase","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-23","type":"pipeline","source":"simplywall.st","summary":"Are Strong Financial Prospects The Force That Is Driving The Momentum In Cipher Pharmaceuticals Inc.'s TSE:CPH) Stock? - simplywall.st","headline":"Are Strong Financial Prospects The Force That Is Driving The Momentum In Cipher Pharmaceuticals Inc.'s TSE:CPH) Stock?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOWUEweWFFOFdFV2RXdDlpR0l4SmROTzRlaWlGOE5ZTDJ5ZjhhV1lwMklEb3RGTFRSZk42MHZVTnlJTjU3MDZYdEc5RUlwZEdKRkVWZE50S2tKdWUyZzNRd0ZVLXVndVFEemtxZTRVa1lOUU1VT3laQU1NTlU4WWlESFI4SQ?oc=5","date":"2025-11-22","type":"pipeline","source":"seekingalpha.com","summary":"Cipher Pharmaceuticals Has Potential (OTCMKTS:CPHRF) - seekingalpha.com","headline":"Cipher Pharmaceuticals Has Potential (OTCMKTS:CPHRF)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-09","type":"pipeline","source":"simplywall.st","summary":"Cipher Pharmaceuticals Inc. (TSE:CPH) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st","headline":"Cipher Pharmaceuticals Inc. (TSE:CPH) Analysts Are Pretty Bullish On The Stock After Recent Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPRUxHbkN5aWlnRmtER3ZkS3FoLVhsb2tweFcxb1p0dzN4TU9IZ2E0b0g5TEgxeUVUUXcxbXBpYXBab1E5VUtCamtJSm44d0N4NG9kVlBnNVpCc21SMExZMHNSR1ZzeGZUSVhyalVUVzBMQl9rekY2VmhVYnh2eWI4b2R0aGlWd0xfWDUxUW9LMl9yNXNJbEtvLTltcGNwZnFqX3luRlNVZ0llMS01a0tCc2Y2Y3o1QTFwMlpNZnVUSVl2NzNhWXdubmw1d2N3UGc?oc=5","date":"2025-11-07","type":"earnings","source":"Investing.com","summary":"Earnings call transcript: Cipher Pharmaceuticals Q3 2025 beats EPS expectations - Investing.com","headline":"Earnings call transcript: Cipher Pharmaceuticals Q3 2025 beats EPS expectations","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQWklSLWgtQjBuUmlJenc4SXhxeEtzc0R0Nl9zWDU1a3JXeWVOM2M3REtJX0pTeVN5bUdWSTd6UzJpbXE0Tm9BVU90dXhDOGZqem54N2Jwdk1fRER3ci1rS1J4enpCVjU2Q0ZFbEVDZFM5azVXZ3FMM25GV092UEIxejJXcXE1bjE5NlJwVHpBMlBTQVpxaVVONnktcnpQcGwtSUE?oc=5","date":"2025-10-14","type":"pipeline","source":"Yahoo Finance","summary":"Cipher Pharmaceuticals Receives Successful Arbitration Award - Yahoo Finance","headline":"Cipher Pharmaceuticals Receives Successful Arbitration Award","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQTlhIN1RPMHlGbm9nd25iZS1oXzV2SFdLREtXMXpvd2JoS2NoZW5IY2hqSDFYWnotdTNnRFB6Q25OMmVtLUd6dHN4MzJ5MlQ1RXg2aEs4VFdTclZmdWpyeEhYSjRBUm5haVZBVEZTbU1NaExSMGVtTEV3WGxpRE1JMHRta3ZqVXpITWZKS3dSUHdUYTNl0gFWQVVfeXFMUHUzcm1ib01PU1NGc09TbUdPbnBkeTNxdS1sYnMwMTdaLUlSSW9KNkUwOWtGam5BS2RLbnU5WmxoVm5wWTdaMTE4Y3otdjVWZ240ak5iMWc?oc=5","date":"2025-10-09","type":"pipeline","source":"Law360","summary":"Pharma Co. Looks To Nix 'Absurd' Award Over Acne Drug - Law360","headline":"Pharma Co. Looks To Nix 'Absurd' Award Over Acne Drug - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTFB2R0JISnlzWGxLMkdWZ2VqeGhFR2Rpbi1SZXg1Q3pvSzAwMF8wV0E1QzZqN1ppY09xNU9XczFSbXpLWHhZd3pfUGM5T2VOOXdCLTFJVzFOdVNrU19MMUE?oc=5","date":"2025-07-25","type":"pipeline","source":"Finimize","summary":"Cipher Pharma’s Bet On Dermatology Delivers Standout Growth - Finimize","headline":"Cipher Pharma’s Bet On Dermatology Delivers Standout Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNS0pQRDdQc3hTTmZhU0JzNGJZay16ZXJMbmRiN3lCVTRJcWFVZG92V3pPeXgybGVWVk5RUmdSVWdIZ0s0SzhfX0s4UmJqX2FxZGpxRUd1Um53RVBrNEpDNkRncjRjVnZkOGFtOUZSR1VJUnRheWpmSXhJc3Blcm4zLXRRZjNBZ2ZUdC04VW5OMmhHdEluNF9OX09hWUM3Q182dWtzRW1QMG5UV2g5a25RWkRlUGI4M1E5YUs5NjBEVWVWbWdLNDFRdml3SlpEalhSem5fdG9lYkVrN0FRNkthSTBRbWdIMlVw?oc=5","date":"2025-07-23","type":"earnings","source":"Investing.com","summary":"Cipher Pharmaceuticals Q1 2025 slides: Natroba acquisition drives revenue growth despite EPS miss - Investing.com","headline":"Cipher Pharmaceuticals Q1 2025 slides: Natroba acquisition drives revenue growth despite EPS miss","sentiment":"negative"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}